Elevance Health
760 hedge funds and large institutions have $34.8B invested in Elevance Health in 2015 Q3 according to their latest regulatory filings, with 66 funds opening new positions, 267 increasing their positions, 298 reducing their positions, and 80 closing their positions.
3.54% more ownership
Funds ownership: 86.57% → 90.11% (+3.5%)
3% less funds holding
Funds holding: 780 → 760 (-20)
7% less capital invested
Capital invested by funds: $37.3B → $34.8B (-$2.51B)
10% less repeat investments, than reductions
Existing positions increased: 267 | Existing positions reduced: 298
11% less funds holding in top 10
Funds holding in top 10: 38 → 34 (-4)
12% less call options, than puts
Call options by funds: $142M | Put options by funds: $161M
18% less first-time investments, than exits
New positions opened: 66 | Existing positions closed: 80
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.16B |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
+$602M |
| 3 |
Public Sector Pension Investment Board (PSP Investments)
Montreal,
Quebec, Canada
|
+$170M |
| 4 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$135M |
| 5 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$131M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Allianz Asset Management
Munich,
Germany
|
-$249M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$238M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$227M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$220M |
| 5 |
JP Morgan Chase
New York
|
-$181M |
ELV Hedge Fund Activity: Q3 2015 in Review
760 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q3 2015, worth a combined $34.8B — down 6.7% from $37.3B a quarter earlier.
Sellers outnumbered buyers: 80 funds closed out of ELV and 66 opened new positions — a net loss of 14 holders — while 298 trimmed existing stakes and 267 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $1.16B. The largest seller was Allianz Asset Management, cutting an estimated $249M.
- 760 institutional investors held Elevance Health (ELV) as of Q3 2015, down from 780 in Q2 2015.
- Funds reported $34.8B of Elevance Health stock for Q3 2015, down 6.7% quarter-over-quarter.
- 66 funds opened new Elevance Health positions in Q3 2015 and 80 closed out, a net change of -14 holders.
- The largest Elevance Health buyer in Q3 2015 was T. Rowe Price Associates, an estimated $1.16B added.
- The largest Elevance Health seller in Q3 2015 was Allianz Asset Management, an estimated $249M sold.
Based on aggregated 13F filings for Q3 2015.